Protoporphyrin-IX accumulation and cutaneous tumor regression in mice using a ferrochelatase inhibitor

Cancer Letters

Volumn 187, Issue 1-2, 2002, Pages 9-16

  Bhasin, Gayatri ^a   Kausar, Hina ^a   Athar, Mohammad ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Aminolaevulinic acid; Ferrochelatase; Photodynamic therapy of cancer; Protoporphyrin IX

Indexed keywords

LEAD ACETATE; PROTOPORPHYRIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; LIGHT EXPOSURE; LYMPHOCYTE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN PAPILLOMA; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR REGRESSION;

ANIMALS; ENZYME INHIBITORS; FEMALE; FERROCHELATASE; LIGHT; MICE; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; PROTOPORPHYRINS; SKIN; SKIN NEOPLASMS;

ANIMALIA;

EID: 0037058640     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00284-7     Document Type: Article

References (22)

1. Forbes I.J., Cowled P.A., Leong A.S.Y., Ward A.D., Black R.B., Blake I., Jacka F.J. Phototherapy of human tumors using hematoporphyrin derivative. Med. J. Aust. 2:1980;489-492.
2. Larsen N.S. Regulatory approval and technological advances raise hopes for photodynamic therapy. J. Natl Cancer Inst. 85:1993;1453-1454.
3. Dougherty T.J., Marcus S.L. Photodynamic therapy. Eur. J. Cancer. 28A:1992;1734-1742.
4. Bedwell J., MacRobert A.J., Phillips D., Brown S.G. Fluorescence distribution and photodynamic effect of ALA-induced PPIX in the DMH rat colonic tumor model. Br. J. Cancer. 65:1992;818-824.
5. Loh C.S., MacRobert A.J., Bedwell J. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br. J. Cancer. 68:1993;41-51.
6. Hermes-Lima M.V., Valle G.R., Vercesi A.E., Bechara E.J.H. Damage to rat liver mitochondria promoted by δ-aminolevulinic acid-generated reactive oxygen species: connections with acute intermittent porphyria and lead poisoning. Biochem. Biophys. Acta. 1056:1991;57-63.
7. Emanuelli T., Pagel F.W., Alves L.B., Regner A., Souza D.O. Inhibition of adenylate cyclase activity by 5-aminolevulinic acid in rat and human brain. Neurochem. Int. 38:2001;213-218.
8. Mitchell G., Larochelle J., Lambert M., Michaud J., Grenier A., Ogier H., Gauthier M., Lacroix J., Vanasse M., Larbrisseau A. Neurologic crises in hereditory tyrosinemia. N. Engl. J. Med. 49:1990;432-437.
9. Gorchein A., Webber R. δ-Aminolaevulinic acid in plasma, cerebrospinal fluid, saliva and erythrocytes: studies in normal, uraemic and porphyric subjects. Clin. Sci. 72:1987;103-112.
10. Bhasin G., Kausar H., Athar M. Ferrochelatasea novel target for photodynamic therapy of cancer. Oncol. Rep. 6:1999;1429-1432.
11. Kriegmair M., Baumgartner R., Knuechel R. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology. 44:1994;836-841.
12. Hennings H., Shores R., Wenk M.L., Spanger E.F., Tarone R., Vuspa S.H. Malignant conversion of mouse skin tumors is increased by tumor initiators and unaffected by tumor promoters. Nature. 304:1983;67-69.
13. Tripathy B.C., Rebeiz C.A. Demonstration of monovinyl and divinyl monocarboxylic routes of chlorophyll biosynthesis in higher plants. J. Biol. Chem. 261:1986;13556-13564.
14. Lowry O.H., Rosebraugh N.J., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
15. Luna L.G. Manual of Histological Staining Methods of the Armed Forces Institute of Pathology. 3rd ed. (1968);McGraw-Hill, New York, NY. 33-49.
16. Kennedy J.C., Pottier R.H., Pross D.C. Photodynamic therapy with endogenous protoporphyrin-IX: basic principles and present clinical experience. J. Photochem. Photobiol. B. 6:1990;143-148.
17. Kennedy J.C., Pottier R.H. Using ALA in cancer therapy. Duke S.O., Rebeiz C.A., Porphyric Pesticides: Design, Mechanism of Action, Toxicology and Relationship to Pharmaceutical. 1968;291-302 American Chemical Society, Washington, DC.
18. Peng Q., Moan J., Warlow T., Nesland J.M., Rimington C. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int. J. Cancer. 52:1992;433-443.
19. Wolf P., Rieger E., Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas and basal cell carcinomas. J. Am. Acad. Dermatol. 28:1993;17-21.
20. Henderson B.W., Dougherty T.J. How does photodynamic therapy work? Photochem. Photobiol. 55:1992;145-157.
21. Fingar V.H., Wieman T.J., McMahon K.S., Haydon P.S., Halling B.P., Yuhas D.A., Winkelman J.W. Photodynamic therapy using a protoporphyrinogen oxidase inhibitor. Cancer Res. 57:1997;4551-4556.
22. Fukuda H., Caras A., Chueke P., Paredes S., Battle A.M.C. Photodynamic action of endogenously synthesized porphyrins from aminolevulinic acid using a new model for assaying the effectiveness of tumor cell killing. Int. J. Biochem. 25:1993;1395-1398.